Rapid Therapeutic Science Laboratories, Inc. (OTCPK:RTSL) signed a letter of intent (LOI) to acquire all of the Assets of Razor Jacket, LLC from Frank Gill and Ryan Johnson on September 30, 2020. On October 23, 2020, Rapid Therapeutic Science Laboratories entered into an agreement to acquire all of the Assets of Razor Jacket, LLC from Frank Gill and Ryan Johnson for approximately $15.7 million. As per the agreement, cash consideration of 0.3 million and 0.625 million common shares to paid. Additional consideration of 16.5 million convertible preferred stock to be paid upon certain performance after closing. For the six months ended September 30, 2020, Razor Jacket, LLC reported total assets of $36,111; revenues of $94,750; and net income of $56,545. Frank Gill and Ryan Johnson shall stay with the company. Ryan Johnson is to serve as Chief Operating Officer of the company and shall be appointed as a member of the Board of Directors of Rapid Therapeutic Science Laboratories closing with all rights and compensation thereof while Frank Gill is to serve as Chief Isolate Laboratory Technician of the company. The transaction is subject customary closing conditions including Rapid Therapeutic Science Laboratories' board approval and execution of employment and intellectual property agreements. The transaction is not anticipated to close until after October 31, 2020, provided that the closing is required to occur prior to November 30, 2020, subject to the satisfaction of the closing conditions.